Efficacy and Tolerability of Calcitonin Gene-Related Peptide Targeted Monoclonal Antibody Medications as Add-on Therapy to OnabotulinumtoxinA in Patients with Chronic Migraine.
Sign Up to like & getrecommendations! Published in 2021 at "Pain medicine"
DOI: 10.1093/pm/pnab093
Abstract: BACKGROUND We examined the efficacy and tolerability of calcitonin gene-related peptide targeted monoclonal antibodies (CGRP-targeted mAbs) as add-on therapy for patients with chronic migraine (CM) undergoing treatment with onabotulinumtoxinA(onabot) who require additional preventive therapy. METHODS… read more here.
Keywords: cgrp targeted; targeted mab; tolerability; tolerability calcitonin ... See more keywords